Interventional Cardiology and Catheter-Based Interventions in Pregnancy.
Journal
Cardiology in review
ISSN: 1538-4683
Titre abrégé: Cardiol Rev
Pays: United States
ID NLM: 9304686
Informations de publication
Date de publication:
Historique:
pubmed:
8
10
2020
medline:
30
12
2021
entrez:
7
10
2020
Statut:
ppublish
Résumé
Cardiovascular disease is the leading cause of maternal mortality worldwide and has been increasing in prevalence over the last several decades. Pregnancy is associated with significant hemodynamic changes that can overwhelm the maternal cardiovascular reserve, and may exacerbate previously asymptomatic cardiovascular disease. Complications associated with these may cause substantial harm to both the mother and the fetus, and the management of these conditions is often challenging. Numerous novel treatments and interventions have demonstrated the safety and efficacy of managing these conditions outside of pregnancy. However, there are little data regarding their use in the pregnant population. In this review, we describe the common cardiovascular diseases encountered during pregnancy and discuss their management strategies, with a particular focus on the role of percutaneous, catheter-based therapeutic interventions.
Identifiants
pubmed: 33027066
pii: 00045415-202201000-00004
doi: 10.1097/CRD.0000000000000361
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
24-30Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure: The authors have no conflicts of interest to report.
Références
Stout KK, Otto CM. Pregnancy in women with valvular heart disease. Heart. 2007;93:552–558.
Lima FV, Yang J, Xu J, et al. National trends and in-hospital outcomes in pregnant women with heart disease in the United States. Am J Cardiol. 2017;119:1694–1700.
Presbitero P, Zavallani D, Agnoli B. Cardiac emergencies in pregnancy. Tubaro M, Vranthkx P, Price S, et al, eds. In: The ESC Textbook of Intensive and Acute Cardiovascular Care. 2nd ed. Oxford, United Kingdom: Oxford University Press; 2015:600–614.
Berg CJ, Callaghan WM, Henderson Z, et al. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol. 2011;117:1230.
Soma-Pillay P, Nelson-Piercy C, Tolppanen H, et al. Physiological changes in pregnancy. Cardiovasc J Afr. 2016;27:89–94.
Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130:1003–1008.
Gupta R, Ranchal P, Harburger J. Mechanical valve thrombosis in a pregnant patient: a case of therapeutic failure. Cureus. 2019;11:e5615.
Ouzounian JG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiol Clin. 2012;30:317–329.
Gupta R, Malik AH, Ranchal P, et al. Valvular heart disease in pregnancy: anticoagulation and the role of percutaneous treatment. Curr Probl Cardiol. 2020;30:100679.
John AS, Gurley F, Schaff HV, et al. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg. 2011;91:1191–1196.
Elassy SM, Elmidany AA, Elbawab HY. Urgent cardiac surgery during pregnancy: a continuous challenge. Ann Thorac Surg. 2014;97:1624–1629.
Presbitero P, Prever SB, Brusca A. Interventional cardiology in pregnancy. Eur Heart J. 1996;17:182–188.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al.; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165–3241.
Balci A, Sollie-Szarynska KM, van der Bijl AG, et al.; ZAHARA-II investigators. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014;100:1373–1381.
Elkayam U, Goland S, Pieper PG, et al. High-risk cardiac disease in pregnancy: part I. J Am Coll Cardiol. 2016;68:396–410.
Roos-Hesselink JW, Duvekot JJ, Thorne SA. Pregnancy in high risk cardiac conditions. Heart. 2009;95:680–686.
Yoon I, Slesinger TL. Radiation Exposure in Pregnancy. Treasure Island, FL: StatPearls; 2020.
Orchard E, Dix S, Wilson N, et al. Reducing ionizing radiation doses during cardiac interventions in pregnant women. Obstet Med. 2012;5:108–111.
Silversides CK, Colman JM, Sermer M, et al. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol. 2003;91:1382–1385.
Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001;37:893–899.
Inoue K, Owaki T, Nakamura T, et al. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984;87:394–402.
Lock JE, Khalilullah M, Shrivastava S, et al. Percutaneous catheter commissurotomy in rheumatic mitral stenosis. N Engl J Med. 1985;313:1515–1518.
de Souza JA, Martinez EE Jr, Ambrose JA, et al. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy. J Am Coll Cardiol. 2001;37:900–903.
Nishimura RA, Otto CM, Bonow RO, et al.; ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:2440–2492.
Salem DN, O’Gara PT, Madias C, et al. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(suppl 6):593S–629S.
Wilkins GT, Weyman AE, Abascal VM, et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60:299–308.
Palacios IF, Sanchez PL, Harrell LC, et al. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation. 2002;105:1465–1471.
Mayes CE, Cigarroa JE, Lange RA, et al. Percutaneous mitral balloon valvuloplasty. Clin Cardiol. 1999;22:501–503.
Baumgartner H, Falk V, Bax JJ, et al.; ESC Scientific Document Group. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–2791.
Nanna M, Stergiopoulos K. Pregnancy complicated by valvular heart disease: an update. J Am Heart Assoc. 2014;3:e000712.
Orwat S, Diller GP, van Hagen IM, et al.; ROPAC Investigators. Risk of pregnancy in moderate and severe aortic stenosis: from the multinational ROPAC registry. J Am Coll Cardiol. 2016;68:1727–1737.
Silversides CK, Colman JM, Sermer M, et al. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol. 2003;91:1386–1389.
Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J. 2003;24:761–781.
McKellar SH, MacDonald RJ, Michelena HI, et al. Frequency of cardiovascular events in women with a congenitally bicuspid aortic valve in a single community and effect of pregnancy on events. Am J Cardiol. 2011;107:96–99.
Cauldwell M, Johnson M, Jahangiri M, et al. Cardiac interventions and cardiac surgery and pregnancy. Int J Cardiol. 2019;276:43–47.
Hodson R, Kirker E, Swanson J, et al. Transcatheter aortic valve replacement during pregnancy. Circ Cardiovasc Interv. 2016;9:e004006.
Drenthen W, Pieper PG, Roos-Hesselink JW, et al.; ZAHARA investigators. Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis. Heart. 2006;92:1838–1843.
Samiei N, Amirsardari M, Rezaei Y, et al. Echocardiographic evaluation of hemodynamic changes in left-sided heart valves in pregnant women with valvular heart disease. Am J Cardiol. 2016;118:1046–1052.
Galal MO, Jadoon S, Momenah TS. Pulmonary valvuloplasty in a pregnant woman using sole transthoracic echo guidance: technical considerations. Can J Cardiol. 2015;31:103.e5–103.e7.
van Hagen IM, Thorne SA, Taha N, et al.; ROPAC Investigators and EORP Team. Pregnancy outcomes in women with rheumatic mitral valve disease: results from the registry of pregnancy and cardiac disease. Circulation. 2018;137:806–816.
Smith PK, Puskas JD, Ascheim DD, et al.; Cardiothoracic Surgical Trials Network Investigators. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371:2178–2188.
Whitlow PL, Feldman T, Pedersen WR, et al.; EVEREST II Investigators. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (endovascular valve edge-to-edge repair) high risk study. J Am Coll Cardiol. 2012;59:130–139.
Berry N, Sawlani N, Economy K, et al. Transcatheter aortic valve replacement for bioprosthetic aortic stenosis in pregnancy. JACC Cardiovasc Interv. 2018;11:e161–e162.
Herbert KA, Sheppard SM. Not your typical dyspnea of pregnancy: a case report of transcatheter valve-in-valve replacement during pregnancy. A A Pract. 2019;12:202–204.
Chengode S, Shabadi RV, Rao RN, et al. Perioperative management of transcatheter, aortic and mitral, double valve-in-valve implantation during pregnancy through left ventricular apical approach. Ann Card Anaesth. 2018;21:185–188.
Bredy C, Mongeon FP, Leduc L, et al. Pregnancy in adults with repaired/unrepaired atrial septal defect. J Thorac Dis. 2018;10(suppl 24):S2945–S2952.
Manivannan S, Dadlani G, Parsons M, et al. Surgical repair of atrial septal defect with severe pulmonary hypertension during pregnancy: a case report with literature review. Cardiol Young. 2012;22:493–498.
Olsson KM, Channick R. Pregnancy in pulmonary arterial hypertension. Eur Respir Rev. 2016;25:431–437.
Galiè N, Humbert M, Vachiery JL, et al.; ESC Scientific Document Group. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119.
Kiely DG, Condliffe R, Webster V, et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG. 2010;117:565–574.
Kenyon KW, Nappi JM. Bosentan for the treatment of pulmonary arterial hypertension. Ann Pharmacother. 2003;37:1055–1062.
James AH, Jamison MG, Biswas MS, et al. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation. 2006;113:1564–1571.
Badui E, Enciso R. Acute myocardial infarction during pregnancy and puerperium: a review. Angiology. 1996;47:739–756.
Usta IM, Abdallah M, El-Hajj M, et al. Massive subchorionic hematomas following thrombolytic therapy in pregnancy. Obstet Gynecol. 2004;103(5 pt 2):1079–1082.
Yin SH, Xu P, Wang B, et al. Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis. BMJ. 2019;365:l2222.
Macaya F, Salinas P, Gonzalo N, et al. Spontaneous coronary artery dissection: contemporary aspects of diagnosis and patient management. Open Heart. 2018;5:e000884.
Elkayam U, Jalnapurkar S, Barakkat MN, et al. Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011. Circulation. 2014;129:1695–1702.
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354:2443–2451.
Hilfiker-Kleiner D, Haghikia A, Berliner D, et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017;38:2671–2679.
Gevaert S, Van Belleghem Y, Bouchez S, et al. Acute and critically ill peripartum cardiomyopathy and ‘bridge to’ therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care. 2011;15:R93.
Gersh BJ, Maron BJ, Bonow RO, et al.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58:e212–e260.
Gi WT, Amr A, Sedaghat-Hamedani F, et al. Two hearts at risk: emergency alcohol septal ablation in a pregnant woman with decompensated HOCM. JACC Case Rep. 2020;2:139–144.
Mitsui T, Masuyama H, Ejiri K, et al. A pregnancy with severe hypertrophic obstructive cardiomyopathy after surgery for an implantable cardioverter defibrillator: a case report and literature review. Case Rep Obstet Gynecol. 2016;2016:4690790.